Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A Viral Platform for Chemical Modification and Multivalent Display.

David S Peabody1

  • 1Department of Molecular Genetics and Microbiology and the Cancer Research and Treatment Center University of New Mexico School of Medicine Albuquerque, New Mexico, USA 87131. dpeabody@salud.unm.edu

Journal of Nanobiotechnology
|August 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smart Nucleic Acid Chaperones: Phase-Separating Intrinsically Disordered Proteins for Accelerating DNA Hybridization Reactions.

ACS synthetic biology·2026
Same author

Isolation of nucleic acids using liquid-liquid phase separation of pH-sensitive elastin-like polypeptides.

Scientific reports·2024
Same author

An Approach for Antigen-Agnostic Identification of Virus-Like Particle-Displayed Epitopes that Engage Specific Antibody V Gene Regions.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice.

Biomolecules·2023
Same author

A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology.

Virology·2023
Same author

RNA Phage VLP-Based Vaccine Platforms.

Pharmaceuticals (Basel, Switzerland)·2021

Researchers chemically modified MS2 bacteriophage surfaces by substituting amino acids to create accessible sulfhydryl groups. This engineering enables precise chemical attachment for biotechnology and nanotechnology applications.

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Molecular Electronics
  • Virology
  • Protein Engineering

Background:

  • Chemically modifying virus surfaces enables applications in biotechnology, nanotechnology, and molecular electronics.
  • RNA phages, like MS2, are suitable scaffolds for attaching substances in defined patterns due to their structure.
  • Specific chemical modifications require engineered surface sites on the virus-like particle.

Purpose of the Study:

  • To engineer MS2 bacteriophage for specific chemical surface modification.
  • To introduce accessible sulfhydryl groups onto the MS2 virus-like particle surface.
  • To create a functional virus-based scaffold for advanced applications.

Main Methods:

Related Experiment Videos

  • Site-directed mutagenesis was used to substitute surface amino acids with cysteine residues in the MS2 coat protein.
  • Analysis of coat protein folding and stability was performed for engineered variants.
  • Characterization of virus-like particles to confirm structural integrity and accessibility of introduced functional groups.

    • Main Results:

    • Several cysteine substitutions were introduced onto the MS2 surface.
    • Some substitutions led to defects in coat protein folding or particle stability.
    • One specific substitution yielded a stable, normal virus-like particle with an accessible surface sulfhydryl group.

    Conclusions:

    • Engineered MS2 bacteriophage can present accessible sulfhydryl groups on its surface.
    • This modification provides a platform for targeted chemical conjugation.
    • The engineered MS2 particles hold potential for use in biotechnology and nanotechnology.